March 31, 2026 · Form 4 insider transaction
Twitty Christopher bought 12,000 shares of Skye Bioscience, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing.; On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged.; The stock option vests 25% on December 8, 2023 and 1/48th monthly thereafter. The grant date for the stock option is January 5, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested.